Treatments for COVID-19: emerging drugs against the coronavirus

Main Article Content

Sara Khademolhosseini
Hadiseh Kavandi
Samad Ghaffari

Keywords

COVID-19 , Reserpine , COPB2

Abstract

N/A

a

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Abstract 45 | PDF Downloads 17

References

1. Potì F, Pozzoli C, Adami M, Poli E, Costa LG. Treatments for COVID-19: emerging drugs against the coronavirus. Acta Bio-Medica Atenei Parm. 2020 May 11;91(2):118–36.
2. Duarte RRR, Copertino Jr. DC, Iñiguez LP, Marston JL, Nixon DF, Powell TR. Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach. 2020 Apr 21 [cited 2020 Jun 2]; Available from: https://chemrxiv.org/articles/Repurposing_FDA-Approved_Drugs_for_COVID-19_Using_a_Data-Driven_Approach/12148764
3. Wilde AH de, Wannee KF, Scholte FEM et al. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins. J Virol. 2015 Aug 15;89(16):8318–33.
4. Avchaciov K, Burmistrova O, Fedichev PO. AI for the repurposing of approved or investigational drugs against COVID-19. Res Gate Doi Doi. 2020;10.
5. Wu C-Y, Jan J-T, Ma S-H et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci. 2004 Jul 6;101(27):10012–7.